Establishing Value in an Uncertain and Dynamic Landscape

  • This page as PDF


On June 5, The Evidence Base published an article entitled, “Navigating uncertainty: redefining healthcare value in an evolving healthcare landscape,” covering key topics from Avalere’s ISPOR theater session. 

Recent US and global policy developments (i.e., Joint Clinical Assessment, Inflation Reduction Act, FDA Data Requirements), evolving stakeholder expectations, and enhanced focus on sustained access have intensified manufacturer requirements for  demonstrating value. Against this landscape, life science companies need to evolve their value demonstration strategies to be successful in this dynamic environment. 

At ISPOR 2024 in Atlanta, Avalere Health presented the session, “No Longer Business as Usual: Establishing Value in an Uncertain and Dynamic Landscape,” which delved into methods for creating a coherent value strategy amidst this changing policy landscape. The article, published by The Evidence Base, provides a deep dive into the information shared during this session, including challenges and actionable strategies for life sciences companies.  

To read the full article, visit The Evidence Base 

To learn more about how Avalere can assist you, connect with us. 


Webinar | Election 2024: What’s at Stake for Healthcare? 

On August 14 at 1:30 PM ET, Avalere experts and guests will discuss the 2024 elections, exploring the candidates’ health policy approaches and implications for stakeholders. 

Learn More

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about RWE and Patient-Centered Outcomes
Please enter your email address to be notified when new RWE and Patient-Centered Outcomes insights are published.

Back To Top